About Network Immunology
Network Immunology Inc. is a privately held Vancouver-based preclinical stage biotechnology company focused on discovering and developing novel therapies for inflammatory diseases.
Network Immunology creates lasting value through pioneering research in the field of immunology which leads to new product concepts, product development, and finally to the licensing and commercialization of those products and associated intellectual property.
The mission of Network Immunology is to improve the quality of human life through the development and commercialization of patented immuno-therapeutics.
We are maintaining and strengthening our position as world leader in the development of immuno-therapeutics based on immune network theory.
Network Immunology has collaborators at several North American universities.